Let Us Simplify Drug Formulation

Leverage more than 60 years of solid oral dose design expertise to optimize your injectable formulations.
CC_SOD_Hero_Desktop

Innovation & Expertise Matter in Solid Oral Dose Development

With GLP-1 driving the shift from injectables to solid oral dose, picking the right partner can make all the difference. From excipient selection to shelf-stable formulation design, let us troubleshoot and overcome every development challenge you may face, keeping patient experience and therapeutic performance at the forefront.

From Injectable to Tablet: What it Takes to Make the Switch

Developing an oral dosage form takes more than simply turning an injectable into a tablet or capsule. To do it well, you need the right formulation strategy from the inside out, balancing manufacturability, stability, protection and patient experience.
Read More
opt-iStock-2230721099

Why Oral GLP-1 is Driving the Shift from Injectables to Solid Oral Dose

While injectable GLP-1 therapies have transformed treatment, the rise of oral formats highlights a broader opportunity: creating medicines that are easier to take, distribute, and integrate into everyday life.
Read More
opt-iStock-1325708742
Icon_Download

Quick Guide

What to Consider When Converting from Injectable to Solid Oral Dose

Converting an injectable to a tablet or capsule involves more than changing the dosage form. It requires understanding the API, target PK profile, formulation strategy and scale-up path.
Download

Start the Conversation With Our Solid Oral Dose Experts